










 













 













 




Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version














Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version















 
  Invus Public Equities Advisors L.L.C. SEC 13F-HR filings and top portfolio holdings
 - stockzoa










stockzoa



 
 


			      Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.
		      










Invus Public Equities Advisors L.L.C.



 Latest statistics and disclosures from Invus Public Equities Advisors's latest quarterly 13F-HR filing: 
  
 
      Top 5 stock holdings are 
      
        GS,
      
        ACOR,
      
        AUXL,
      
        GOOG,
      
        MET,
      
      and represent 33.60%  of Invus Public Equities Advisors's stock portfolio. 
    
 
      Added to shares of these 10 stocks:
      
        
          
            GS (+$56.56M),
          
        
      
        
          
            ACOR (+$54.93M),
          
        
      
        
          
            AUXL (+$49.98M),
          
        
      
        
          
            GOOG (+$40.51M),
          
        
      
        
          
            MET (+$35.10M),
          
        
      
        
          
            JPM (+$32.75M),
          
        
      
        
          
            ESRX (+$29.69M),
          
        
      
        
          
            WFC (+$28.06M),
          
        
      
        
          
            CSCO (+$23.41M),
          
        
      
        
          
            PFE (+$20.60M).
          
        
      
    
 
      Started 51 new stock positions in 
      
        
          
            ACOR,
          
        
      
        
          
            shares Agenus Inc,
          
        
      
        
          
            HCA HOLDINGS Inc,
          
        
      
        
          
            Bg Medicine Inc,
          
        
      
        
          
            BRFS,
          
        
      
        
          
            EWZ,
          
        
      
        
          
            GM,
          
        
      
        
          
            MMI,
          
        
      
        
          
            SMT,
          
        
      
        
          
            GOOG.
          
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
        
      
    

    Invus Public Equities Advisors was a net  buyer  of stock by $705.60M.
    






 Invus Public Equities Advisors portfolio companies for June 2011 quarter  






 Company (Ticker) 
 Portfolio Weight 
 Share Count 
 Price 
 Last Trade 





Goldman Sachs
        
        
          (GS)
        
      
 8.02 

        425000
         NEW 

 133.09 
 223.61 



Acorda Therapeutics
        
        
          (ACOR)
        
      
 7.78 

        1.70M
         NEW 

 32.31 
 21.70 



Auxilium Pharmaceuticals
        
        
          (AUXL)
        
      
 7.08 

        2.55M
         NEW 

 19.60 
 36.47 



Google
        
        
          (GOOG)
        
      
 5.74 

        80000
         NEW 

 506.38 
 941.53 



MetLife
        
        
          (MET)
        
      
 4.97 

        800000
         NEW 

 43.87 
 55.25 



JPMorgan Chase & Co.
        
        
          (JPM)
        
      
 4.64 

        800000
         NEW 

 40.94 
 91.28 



Express Scripts
        
        
          (ESRX)
        
      
 4.21 

        550000
         NEW 

 53.98 
 62.90 



Wells Fargo & Company
        
        
          (WFC)
        
      
 3.98 

        1000000
         NEW 

 28.06 
 53.30 



Cisco Systems
        
        
          (CSCO)
        
      
 3.32 

        1.50M
         NEW 

 15.61 
 31.52 



Pfizer
        
        
          (PFE)
        
      
 2.92 

        1000000
         NEW 

 20.60 
 33.15 



Nektar Therapeutics
        
        
          (NKTR)
        
      
 2.83 

        2.75M
         NEW 

 7.27 
 22.91 



QUALCOMM
        
        
          (QCOM)
        
      
 2.82 

        350000
         NEW 

 56.79 
 52.88 



Martin Marietta Materials
        
        
          (MLM)
        
      
 2.61 

        230000
         NEW 

 79.97 
 226.50 



AVANIR Pharmaceuticals
        
        
          (AVNR)
        
      
 2.45 

        5.15M
         NEW 

 3.36 
 16.96 



Visa
        
        
          (V)
        
      
 2.39 

        200000
         NEW 

 84.26 
 99.15 



Citigroup Inc

 2.36 

        400000
         NEW 

 41.64 
 0.00 



HCA HOLDINGS Inc

 2.34 

        500000
         NEW 

 33.00 
 0.00 



BRF Brasil Foods SA
        
        
          (BRFS)
        
      
 2.09 

        850000
         NEW 

 17.33 
 11.80 



Ford Motor Company
        
        
          (F)
        
      
 1.95 

        1000000
         NEW 

 13.79 
 11.17 



Bank of America Corporation
        
        
          (BAC)
        
      
 1.86 

        1.20M
         NEW 

 10.96 
 24.03 



Onyx Pharmaceuticals
        
        
          (ONXX)
        
      
 1.75 

        350000
         NEW 

 35.30 
 124.70 



General Motors Company
        
        
          (GM)
        
      
 1.72 

        400000
         NEW 

 30.36 
 35.77 



Mindray Medical International
        
        
          (MR)
        
      
 1.69 

        425000
         NEW 

 28.05 
 27.94 



Furiex Pharmaceuticals
        
        
          (FURX)
        
      
 1.58 

        625000
         NEW 

 17.79 
 104.77 



Arch Coal
        
        
          (ACI)
        
      
 1.51 

        400000
         NEW 

 26.66 
 0.99 



Crown Castle International
        
        
          (CCI)
        
      
 1.45 

        250000
         NEW 

 40.79 
 100.58 



American International
        
        
          (AIG)
        
      
 1.25 

        300000
         NEW 

 29.32 
 65.27 



Schlumberger
        
        
          (SLB)
        
      
 1.22 

        100000
         NEW 

 86.40 
 68.46 



Meritor Inc

 1.14 

        500000
         NEW 

 16.04 
 0.00 



MasterCard Incorporated
        
        
          (MA)
        
      
 1.07 

        25000
         NEW 

 301.36 
 127.91 



iShares MSCI Brazil Index
        
        
          (EWZ)
        
      
 1.04 

        100000
         NEW 

 73.35 
 37.39 



Lexicon Pharmaceuticals
        
        
          (LXRX)
        
      
 0.97 

        3.89M
         NEW 

 1.76 
 16.38 



SMART Technologies
        
        
          (SMT)
        
      
 0.89 

        1.10M
         NEW 

 5.70 
 4.49 



Eaton Corporation
        
        
          (ETN)
        
      
 0.73 

        100000
         NEW 

 51.45 
 78.43 



Citigroup Inc unit

 0.73 

        43000
         NEW 

 120.14 
 0.00 



Morgan Stanley
        
        
          (MS)
        
      
 0.65 

        200000
         NEW 

 23.01 
 46.66 



Tata Motors
        
        
          (TTM)
        
      
 0.64 

        200000
         NEW 

 22.51 
 34.60 



Motorola Mobility Holdings, Inc. Common Stock
        
        
          (MMI)
        
      
 0.62 

        200000
         NEW 

 22.04 
 26.38 



Lamar Advertising Company
        
        
          (LAMR)
        
      
 0.54 

        138000
         NEW 

 27.37 
 71.25 



Affymetrix
        
        
          (AFFX)
        
      
 0.37 

        325000
         NEW 

 7.93 
 14.01 



Biodel
        
        
          (BIOD)
        
      
 0.31 

        1.16M
         NEW 

 1.87 
 0.65 



McKesson Corporation
        
        
          (MCK)
        
      
 0.30 

        25000
         NEW 

 83.64 
 162.51 



Pmi Group Inc

 0.30 

        2.00M
         NEW 

 1.07 
 0.00 



Simcere Pharmaceutical
        
        
          (SCR)
        
      
 0.28 

        200000
         NEW 

 9.77 
 0.00 



Beazer Homes USA
        
        
          (BZH)
        
      
 0.24 

        500000
         NEW 

 3.39 
 13.49 



Micromet
        
        
          (MITI)
        
      
 0.20 

        250000
         NEW 

 5.74 
 0.00 



Bg Medicine Inc

 0.16 

        142857
         NEW 

 7.96 
 0.00 



Novagold Resources Inc Cad Com

 0.13 

        100000
         NEW 

 9.20 
 0.00 



Pacific Biosciences of California
        
        
          (PACB)
        
      
 0.10 

        63100
         NEW 

 11.70 
 3.23 



shares Agenus Inc

 0.06 

        500000
         NEW 

 0.78 
 0.00 



Microvision Inc Del *w exp 07/23/201

 0.01 

        360515
         NEW 

 0.21 
 0.00 





      Source: http://www.sec.gov/Archives/edgar/data/1340096/...


      Download CSV 







 Past 13F-HR SEC Filings for Invus Public Equities Advisors 




 Invus Public Equities Advisors 2011 Q1

                  filed April 27, 2011
                


 View All Filings 












 


        © 2016 stockzoa - Simplified 13F-HR Filings.
        

          Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way.  In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. 
        

 














Invus
























 

 


					Invus					 

 menu


















Empowering
owner-managers to
transform their
industries



The freedom to take risks.
The capital to reach the prize.
The advice and commitment to navigate uncharted waters.




All key executives must be owners.
Management runs the company, not Invus.
The business is what matters (not ego).




Vision and a long-term horizon.
Exponential, sustainable value creation.
The experience to know it does not happen in a straight line.




Building sustainable competitive advantage.
Using fundamental customer insights.
Innovating to fulfill real customer needs.





 




Since 1985, equity investors in companies who seek to transform their industries.
Evergreen structure with over $5 billion under management. Offices in New York, Paris, and Hong Kong.
Learn more about us chevron_right


 















Invus Public Equities Advisors LLC: Company Profile - Bloomberg



































































  









Feedback























invus public equities advisors llc
Private Company









Company Profile
Sector: Financials
Industry: Asset Management
Sub-Industry: Wealth Management
Invus Public Equities Advisors, LLC operates as an investment advisory company. The Company serves customers in the State of New York.




Corporate Information
Address:

750 Lexington Avenue
30th Floor
New York, NY 10022
United States


Phone:
1-212-371-1717


Fax:
1-212-371-1829























From The Web












Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data



































Invus Advisors, L.L.C. - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Invus Advisors, L.L.C.
Check out list of companies and businesses related to Invus Advisors, L.L.C.. Find out Invus Advisors, L.L.C. address and contact details. View other people related to Invus Advisors, L.L.C. - coworkers, colleagues, companions, etc.
Address:   

750 LEXINGTON AVENUE, 30TH FLOOR  NEW YORK 10022 NY




Companies related to Invus Advisors, L.L.C.
CIKCompany NamePositionCompany Address0001062822LEXICON PHARMACEUTICALS, INC.8800 TECHNOLOGY FOREST PLACE  THE WOODLANDS 773810001609989Blue Buffalo Pet Products, Inc.11 RIVER ROAD SUITE 103 WILTON 06897




Invus Advisors, L.L.C. on the Web
Persons related to Invus Advisors, L.L.C. - LEXICON PHARMACEUTICALS, INC.NamePositionCityMain  AlanThe WoodlandsNies  AlanThe WoodlandsSantini  AlexanderThe WoodlandsPhilippe  AmouyalDirector NEW YORKPhilippe  AmouyalDirector THE WOODLANDSPhilippe  AmouyalDirector THE WOODLANDSGROUP S A  ARTALLUXEMBOURGGroup S.A.  ArtalLUXEMBOURGInternational Management S.A.  ArtalLUXEMBOURGInternational S.C.A.  ArtalDirector LUXEMBOURGINTERNATIONAL SCA  ARTALLUXEMBOURGSands  ArthurThe WoodlandsAJAY  BANSALEVP Corp Dev and CFO THE WOODLANDSSAM L  BARKERDirector THE WOODLANDSSAM L  BARKERDirector THE WOODLANDSZambrowicz  BrianThe WoodlandsPHILIP M  BROWNSVP Clinical Development THE WOODLANDSPHILIP M  BROWNSVP, Clinical Development THE WOODLANDSC THOMAS  CASKEYC THOMAS  CASKEYDirector THE WOODLANDSSobecki  ChristopherThe WoodlandsPATRICIA M  CLOHERTYDirector THE WOODLANDSLONNEL  COATSPresident and CEO THE WOODLANDSWALTER F  COLBERTSVP, HR and Corp Serv THE WOODLANDSRAYMOND  DEBBANEDirector NEW YORKRAYMOND  DEBBANEDirector THE WOODLANDSRAYMOND  DEBBANENEW YORKRAYMOND  DEBBANEDirector THE WOODLANDSRAYMOND  DEBBANENEW YORKRAYMOND  DEBBANENEW YORKPalantoni  FrankThe WoodlandsJULIA P  GREGORYEVP and CFO THE WOODLANDSTAMAR D  HOWSONEVP of Bus Dev THE WOODLANDSC.V.  InvusDirector ROTTERDAMCV  Invus,ROTTERDAM 3068 AVCV  Invus,ROTTERDAM 3068AVCV  Invus,Director ROTTERDAMInvus, L.P.NEW YORKInvus, L.P.NEW YORKInvus, L.P.NEW YORKInvus, L.P.HAMILTON HM IIInvus Public Equities Advisors, LLCNEW YORKInvus Public Equities Advisors, LLCNEW YORKInvus Public Equities, L.P.HAMILTON HM IIInvus Public Equities, LPNEW YORKInvus Public Equities, LPNEW YORKLANCE K  ISHIMOTOSVP, Intellectual Property THE WOODLANDSTessmer  JamesThe WoodlandsWade  JeffreyThe WoodlandsNorthcott  JohnThe WoodlandsSwain  JudithThe WoodlandsPablo  LapuertaEVP and CMO THE WOODLANDSROBERT J MD  LEFKOWITZDirector THE WOODLANDSROBERT J MD  LEFKOWITZDirector THE WOODLANDSCoats  LonnelThe WoodlandsALAN J  MAINEVP, CMC and Supply Operations THE WOODLANDSALAN J  MAINEVP, Pharmaceutical Research THE WOODLANDSBarry  MillsDirector THE WOODLANDSPascal  MinneBRUXELLESALAN S  NIESDirector THE WOODLANDSALAN S  NIESDirector THE WOODLANDSJOHN  NORTHCOTTVP, Marketing, Comm Strategy THE WOODLANDSLapuerta  PabloThe WoodlandsFrank  PalantoniDirector THE WOODLANDSFrank  PalantoniDirector THE WOODLANDSCHRISTOPHE  PERSONVP Informatics THE WOODLANDSBrown  PhilipThe WoodlandsAmouyal  PhilippeThe WoodlandsJAMES R PHD  PIGGOTTSVP of Pharm Bio THE WOODLANDSTyle  PraveenThe WoodlandsDebbane  RaymondThe WoodlandsRANDALL B  RIGGSSVP, Corp Licensing THE WOODLANDSLefkowitz  RobertThe WoodlandsCLAYTON STUART  ROSEDirector THE WOODLANDSBarker  SamuelThe WoodlandsARTHUR T  SANDSPres & CEO THE WOODLANDSARTHUR T  SANDSPresident & CEO THE WOODLANDSAlexander A  SantiniEVP and CCO THE WOODLANDSCAROL  SCHAFERTHE WOODLANDSCHRISTOPHER J  SOBECKIDirector NEW YORKCHRISTOPHER J  SOBECKIDirector THE WOODLANDSCHRISTOPHER J  SOBECKIDirector THE WOODLANDSTragash  StevenThe WoodlandsAdministratiekantoor Westend  StichtingAMSTERDAMJudith L  SwainDirector THE WOODLANDSJudith L  SwainDirector THE WOODLANDSJames F  TessmerVP, Finance & Accounting THE WOODLANDSJames F  TessmerVP, Finance & Accounting THE WOODLANDSSteven Alan  TragashTHE WOODLANDSSteven Alan  TragashVP, Corporate Affairs THE WOODLANDSPRAVEEN  TYLEEVP, R&D ROCHESTERUlys, L.L.C.NEW YORKUlys, LLCDirector NEW YORKJEFFREY L  WADEEVP, Corp Adm Affairs and CFO THE WOODLANDSJEFFREY L  WADEEVP, Corp Dev and CFO THE WOODLANDSS.A.  WESTENDLUXEMBOURGSA  WESTENDLUXEMBOURGKathleen M  WiltseyDirector THE WOODLANDSBRIAN P  ZAMBROWICZEVP, Chief Scientific Officer THE WOODLANDSBRIAN P  ZAMBROWICZEVP, Chief Scientific Officer THE WOODLANDSPersons related to Invus Advisors, L.L.C. - Blue Buffalo Pet Products, Inc.NamePositionCityPhilippe  AmouyalDirector NEW YORKGROUP S A  ARTALNEW YORKInternational Management S.A.  ArtalLUXEMBOURGINTERNATIONAL SA  ARTALEvren  BilimerDirector WILTONChristopher T  Bishop10% Owner WILTONFamily Limited Partnership  BishopDirector WILTONWilliam  BishopDirector WILTONWilliam W  Bishop JRPresident and COO WILTONRAYMOND  DEBBANEDirector NEW YORKMichael A  EckDirector WILTONFrances X  FreiDirector ROANOKEAFLALO SOUSA  GUIMARAESDirector THOUSAND OAKSInvus, L.P.Director NEW YORKPascal  MinneBRUXELLESMichael  NathensonEVP, CFO and Treasurer WILTONStephen J  SaftWILTONKurt  SchmidtChief Executive Officer WILTONAMY W  SCHULMANDirector NEW YORKAdministratiekantoor Westend  Stichting6825BS ARNHEMSA  WESTENDLUXEMBURGWilliam W. Bishop Children's Spray TrustGREENWICH
Potentially same personNameCityCountryInvus Advisors, L.L.C.NEW YORKNY












 











Georgios Theophanous - Associate at Invus Public Equities Advisors LLC



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





Georgios Theophanous
Associate at Invus Public Equities Advisors LLC



Overview
Relationships Paths
Education Career History 


Georgios Theophanous
Associate at Invus Public Equities Advisors LLC



 Overview



Number of Relationships



                This person is connected to 81 people.
              






 Relationships
              See Details




Khalil Barrage

Managing Director, Public Equity at Invus Public Equities Advisors LLC




Robert Mikesell

Director at Invus Public Equities Advisors LLC





Matthew Maslow

Director at Invus Public Equities Advisors LLC




Nicholas Oo

Vice President at Invus Public Equities Advisors LLC





Janet Lee

Former Managing Director, Public Equity, New York at The Invus Group LLC




Joseph Golden

Associate, Public Equity, New York at Invus Public Equities Advisors LLC





Julien Miara

Vice President, Public Equity, Europe at Invus Public Equities Advisors LLC




Olivier Gueymard

Associate, Public Equity, Europe at Invus Public Equities Advisors LLC





Sri Batchu

Head-Finance at Opendoor Labs, Inc.




Nick Beaty

Associate, Public Equities at The Invus Group LLC







See 71 more listings with RelSci Professional.

Start My Free Trial ➤








See 71 More 


 


 Paths to Georgios Theophanous



            Georgios Theophanous          




 You



 Connections via Relationship Science



 Georgios Theophanous






Sync your contacts to see how you can connect with Georgios Theophanous.

Start My Free Trial ➤








See  More 


 


 Educational Background



 


Harvard University

                  Harvard was established in 1636, and it is the oldest institution of higher education in the United States. The University, which is based in Cambridge and Boston, Massachusetts, has an enrollment of over 20,000 degree candidates, including undergraduate, graduate, and professional students. The University has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study.                




 


University of Pennsylvania - The Wharton School

                  The Wharton School is the business school of the University of Pennsylvania, an Ivy League university in Philadelphia, Pennsylvania. Wharton was the world’s first collegiate business school and the first business school in the United States. It was established in 1881 through a donation of Joseph Wharton.                





 Career History



Associate

                                    2013 - Current                


Invus Public Equities Advisors LLC


                  Invus Public Equities Advisors makes majority investments in private, high growth companies. The firm also takes significant, long-term positions in public companies whose fundamentals and management they believe in. Invus focuses on investments in the stocks of small- to mid-cap companies that are trading below the firm's assessment of their intrinsic business value. The average holding period in their public equity portfolio is measured in years. Invus invests in a variety of industries, including but not limited to, consumer products and services, food, specialty retail, software, biotechnology, medical devices, healthcare products and professional services.                




Associate

                                    Prior - 2012                


Vector Capital Management LP


                  Vector Capital focuses exclusively on technology sector. The firm provides capital to businesses through a range of transactions including private buyouts, corporate carve-outs, recapitalizations, growth equity investments, public company buyouts, privatizations and add-on acquisitions. They partner with management teams and align incentives to transform businesses and create value.                




Management Consultant

                                    Prior                


McKinsey & Co., Inc.


                  McKinsey & Co., Inc. provides management consulting services. Its areas of expertise include business technology, corporate finance, marketing and sales, operations, organizational risk and strategy planning, sustainability, and resource productivity. It offers advisory and analytical consulting solutions to commercial and industrial sectors such as electronics, aerospace, automotive, chemicals, media and entertainment, pharmaceuticals, medical, investment, telecommunications, transportation, and logistics. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.                





 Other Affiliations




              Georgios Theophanous is affiliated with
                            Invus Public Equities Advisors LLC, Vector Capital Management LP, McKinsey & Co., Inc..
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤


















Julien Miara - Vice President, Public Equity, Europe at Invus Public Equities Advisors LLC



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





Julien Miara
Vice President, Public Equity, Europe at Invus Public Equities Advisors LLC



Overview
Relationships Paths
Education Career History 


Julien Miara
Vice President, Public Equity, Europe at Invus Public Equities Advisors LLC



 Overview



Number of Relationships



                This person is connected to 45 people.
              






 Relationships
              See Details




Khalil Barrage

Managing Director, Public Equity at Invus Public Equities Advisors LLC




Robert Mikesell

Director at Invus Public Equities Advisors LLC





Janet Lee

Former Managing Director, Public Equity, New York at The Invus Group LLC




Olivier Gueymard

Associate, Public Equity, Europe at Invus Public Equities Advisors LLC





Joseph Golden

Associate, Public Equity, New York at Invus Public Equities Advisors LLC




Julien Marc Sallmard

Principal at The Invus Group LLC





Matthew Maslow

Director at Invus Public Equities Advisors LLC




Nick Beaty

Associate, Public Equities at The Invus Group LLC





Nicholas Oo

Vice President at Invus Public Equities Advisors LLC




Georgios Theophanous

Associate at Invus Public Equities Advisors LLC







See 35 more listings with RelSci Professional.

Start My Free Trial ➤








See 35 More 


 


 Paths to Julien Miara



            Julien Miara          




 You



 Connections via Relationship Science



 Julien Miara






Sync your contacts to see how you can connect with Julien Miara.

Start My Free Trial ➤








See  More 


 


 Educational Background



Master of Management 
Class of 2009 


École des Hautes Études Commerciales du Nord

                  EDHEC Business School (Ecole des Hautes Etudes Commerciales du Nord) is a school.                





 Career History



Vice President, Public Equity, Europe

                                    Current                


Invus Public Equities Advisors LLC


                  Invus Public Equities Advisors makes majority investments in private, high growth companies. The firm also takes significant, long-term positions in public companies whose fundamentals and management they believe in. Invus focuses on investments in the stocks of small- to mid-cap companies that are trading below the firm's assessment of their intrinsic business value. The average holding period in their public equity portfolio is measured in years. Invus invests in a variety of industries, including but not limited to, consumer products and services, food, specialty retail, software, biotechnology, medical devices, healthcare products and professional services.                




Vice President, Public Equity, Europe

                                    2010 - Current                


The Invus Group LLC


                  The Invus Group originates, structures and acts as a lead equity investor in a variety of private equity situations including buy-outs, early-stage venture capital and expansion financings. The firm makes investments in a range of industries including consumer products and services, food, specialty retailing, software, telecommunications, medical devices, biotechnology and business products and services.The Invus Group makes majority control investments in private, high-growth companies. The firm also makes minority investments in high-growth companies where they can add strategic value through partnership with the owners and managers. In addition, the Invus Group takes long-term positions in the stocks of small- to mid-cap companies that are trading below the firm's assessment of their intrinsic business value. The average holding period in their public equity portfolio is measured in years. Most of their investments are in companies located in the US and Europe.                




Investment Banking

                                    Prior                


Société Générale S.A.


                  Societe Generale Corporate & Investment Banking is a leading player with 11,000 professionals in 33 countries across Europe, the Americas and Asia-Pacific. SG CIB tailors solutions for issuers and investors by capitalising on its worldwide expertise in investment banking, global finance, and global markets.                




Investment Banking

                                    Prior                


BNP Paribas SA


                  BNP Parribas is a leader in banking and financial services in Europe. The Group is present in 80 countries. It employs close to 200,000 people, half of which are based in its four ‘domestic’ markets (Belgium, France, Italy and Luxembourg).

The three main activities of BNP Paribas are complementary, providing strategic strength and assuring the bank financial solidity: Retail Banking, Investment Solutions and Corporate & Investment Banking.

By placing the customer firmly at the heart of its operations, “the bank for a changing world” has positioned itself as a responsible company at the service of its customers. It defines itself through its rigorous approach to managing risk, its capacity to adapt and its ability to innovate                





 Other Affiliations




              Julien Miara is affiliated with
                            Invus Public Equities Advisors LLC, The Invus Group LLC, Société Générale S.A., BNP Paribas SA.
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤
















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft









